1. Tan, Jia-Yu, Huang, Xiang, Luo, Ya-Ling. 2012. PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells. In Molecular and cellular biochemistry, 366, 131-7. doi:10.1007/s11010-012-1290-2. https://pubmed.ncbi.nlm.nih.gov/22584585/
2. Jiao, Qing-Hua, Wang, Yan, Zhang, An-Na, Liu, Qian-Qian, Zhou, Qing-Bo. 2023. PSMA7 promotes the malignant proliferation of esophageal cancer. In Heliyon, 10, e23173. doi:10.1016/j.heliyon.2023.e23173. https://pubmed.ncbi.nlm.nih.gov/38173490/
3. Hu, Xiao-Tong, Chen, Wei, Zhang, Fu-Biao, Geng, Shu-Min, He, Chao. . Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration. In Oncology reports, 22, 1247-52. doi:. https://pubmed.ncbi.nlm.nih.gov/19787246/
4. Wang, Sheng, Ye, Wufei, Yang, Kui, Lv, Xiongwen, Luan, Jiajie. 2024. Prognostic Hypoxia-Angiogenesis-Related Gene Signature in Hepatocellular Carcinoma, in Which HILPDA Contributes to Tumor Progression. In Journal of inflammation research, 17, 5663-5683. doi:10.2147/JIR.S476388. https://pubmed.ncbi.nlm.nih.gov/39219818/
5. Liu, Xuan, Huang, Wei, Li, Chufang, Ma, Qingjun, Cao, Cheng. . Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation. In Molecular cell, 22, 317-27. doi:. https://pubmed.ncbi.nlm.nih.gov/16678104/
6. Jia, Yongxia, Song, Ting, Wei, Congwen, Shi, Wei, Zhong, Hui. 2009. Negative regulation of MAVS-mediated innate immune response by PSMA7. In Journal of immunology (Baltimore, Md. : 1950), 183, 4241-8. doi:10.4049/jimmunol.0901646. https://pubmed.ncbi.nlm.nih.gov/19734229/
7. Xiao, Y, Zhang, S-J, Yan, X, Wang, L-J, Hu, Y. . MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7. In European review for medical and pharmacological sciences, 25, 5625-5635. doi:10.26355/eurrev_202109_26782. https://pubmed.ncbi.nlm.nih.gov/34604955/